Citation: Rh. Mathiesen et F. Mo, APPLICATION OF KNOWN TRIPLET PHASES IN THE CRYSTALLOGRAPHIC STUDY OF BOVINE PANCREATIC TRYPSIN-INHIBITOR - II - STUDY AT 2.0 ANGSTROM RESOLUTION, Acta crystallographica. Section D, Biological crystallography, 54, 1998, pp. 237-242
Authors:
MATHIESEN RH
MO F
EIKENES A
NYBORG T
LARSEN HB
Citation: Rh. Mathiesen et al., EXISTENCE OF 2 CRYSTAL-STRUCTURES OF THE COMPLEX ALPHA-D-GLUCOSE-CENTER-DOT-NACL-CENTER-DOT-H2O (2 1/1) VERIFIED BY 3-BEAM DIFFRACTION EXPERIMENTS/, Acta crystallographica. Section A, Foundations of crystallography, 54, 1998, pp. 338-347
Citation: A. Peterman et al., EFFECT OF SYMPTOM TYPE AND SYMPTOM INTENSITY ON MULTIPLE DIMENSIONS OF QUALITY-OF-LIFE, Quality of life research, 6(7-8), 1997, pp. 278-278
Citation: Ah. Peterman et al., PSYCHOMETRIC VALIDATION OF THE REVISED FUNCTIONAL ASSESSMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION (FAHI) QUALITY-OF-LIFE INSTRUMENT, Quality of life research, 6(6), 1997, pp. 572-584
Citation: Rh. Mathiesen et F. Mo, APPLICATION OF KNOWN TRIPLET PHASES IN THE CRYSTALLOGRAPHIC STUDY OF BOVINE PANCREATIC TRYPSIN-INHIBITOR .1. STUDIES AT 1.55 AND 1.75 ANGSTROM RESOLUTION (VOL 53, PG 262, 1997), Acta crystallographica. Section D, Biological crystallography, 53, 1997, pp. 626
Citation: Rh. Mathiesen et F. Mo, APPLICATION OF KNOWN TRIPLET PHASES IN THE CRYSTALLOGRAPHIC STUDY OF BOVINE PANCREATIC TRYPSIN-INHIBITOR .1. STUDIES AT 1.55-ANGSTROM AND 1.75-ANGSTROM RESOLUTION, Acta crystallographica. Section D, Biological crystallography, 53, 1997, pp. 262-268
Authors:
BRADY MJ
CELLA DF
MO F
BONOMI AE
TULSKY DS
LLOYD SR
DEASY S
COBLEIGH M
SHIOMOTO G
Citation: Mj. Brady et al., RELIABILITY AND VALIDITY OF THE FUNCTIONAL ASSESSMENT OF CANCER THERAPY-BREAST QUALITY-OF-LIFE INSTRUMENT, Journal of clinical oncology, 15(3), 1997, pp. 974-986
Authors:
ESPER P
MO F
CHODAK G
SINNER M
CELLA D
PIENTA KJ
Citation: P. Esper et al., MEASURING QUALITY-OF-LIFE IN MEN WITH PROSTATE-CANCER USING THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY PROSTATE INSTRUMENT, Urology, 50(6), 1997, pp. 920-928
Authors:
CELLA DF
MCCAIN NL
PETERMAN AH
MO F
WOLEN D
Citation: Df. Cella et al., DEVELOPMENT AND VALIDATION OF THE FUNCTIONAL ASSESSMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION (FAHI) QUALITY-OF-LIFE INSTRUMENT, Quality of life research, 5(4), 1996, pp. 450-463
Citation: F. Mo et al., APPLICATION OF KNOWN X-RAY PHASES IN THE CRYSTALLOGRAPHIC STUDY OF A SMALL PROTEIN, Acta crystallographica. Section D, Biological crystallography, 52, 1996, pp. 893-900
Authors:
CELLA DF
DINEEN K
ARNASON B
REDER A
WEBSTER KA
KARABATSOS G
CHANG C
LLOYD S
MO F
STEWART J
STEFOSKI D
Citation: Df. Cella et al., VALIDATION OF THE FUNCTIONAL ASSESSMENT OF MULTIPLE-SCLEROSIS QUALITY-OF-LIFE INSTRUMENT, Neurology, 47(1), 1996, pp. 129-139
Authors:
MORKVED EH
NESET SM
BJORLO O
KJOSEN H
HVISTENDAHL G
MO F
Citation: Eh. Morkved et al., PREPARATIONS AND TEMPLATE CYCLOTETRAMERISATIONS OF 2,1,3-BENZOTHIA(SELENA)DIAZOLE-5,6-DICARBONITRILES, Acta chemica Scandinavica, 49(9), 1995, pp. 658-662
Citation: Bc. Hauback et al., STRUCTURES OF 2 MODIFICATIONS OF 1-METHYLTHIO-2-METHYLSULFONYLETHANE AT 87-K, Zeitschrift fur Kristallographie, 209(1), 1994, pp. 60-63
Citation: F. Mo et al., CRYSTALLOGRAPHIC AND SPECTROSCOPIC STUDIES OF 1,2-SN-DIPALMITOYLGLYCEROL WITH A COMMENT ON LIPID PHASES AND MEMBRANES, Journal of physical chemistry, 97(22), 1993, pp. 6083-6089